Now showing items 1-1 of 1

    • Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients 

      Ochs, Michael F.; O'Doherty, Catherine; Favorov, Alexander V.; Heggarty, Shirley; Graham, Colin; Favorova, Olʹga Olegovna; Hawkins, Stanley; Hutchinson, Michael; O'Rourke, Killian; Vandenbroeck, Koen (Future Medicine, 2009)
      IFN-β is widely used as first-line immunomodulatory treatment for multiple sclerosis. Response to treatment is variable (30–50% of patients are nonresponders) and requires a long treatment duration for accurate assessment ...